Profile of the Loulla&Philla project

Project acronym: LOULLA & PHILLA Project

Full title: Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children.

Start date: 1st November 2008

Duration: 36 months

Action line of the FP7 Health programme: HEALTH-2007-4.2-1: Adapting off-patent medicines to the specific needs of paediatric populations

Consortium:

• Only for Children Pharmaceuticals
• ASSISTANCE PUBLIQUE
• HOPITAUX DE PARIS
• COPENHAGEN UNIVERSITY HOSPITAL
• Laboratoire Philippe DAVIOUD SAS
• HEINRICH-HEINE-UNIVERSITÄT DÜSSELDORF
• France Europe Innovation
• PharmaFlow (left the project the 01/10/2009)
• Cardinal Systems
• HOSPICES CIVILS DE LYON
• CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL